Mr. Emmanuel Okwelogu
Emmanuel completed his 5-year Bachelor of Pharmacy degree (B.Pharm) in 2015 at the University of Lagos, Nigeria. In his final year project, he focused on the investigation of antimicrobial properties of phytochemicals extracted from the bark of Morinda Lucida. With a keen interest in advance therapeutics and Nanotechnology, after completion of his professional clinical pharmacy training, Emmanuel obtained an MSc (distinction) in Novel therapies at Imperial College, London in 2019. His collaborative research project between the National Heart and Lung Institute and Dept. of Bioengineering, was focused on the development of biodegradable nanoparticles for gene therapy delivery to lungs epithelial cells.
In 2020, Emmanuel joined the Nanomedicine lab after being offered a 4year CDT PhD studentship in Graphene NOWNANO at the University of Manchester (2019 cohort). His current research is focused on developing 2D nano-corona technology for the analysis of the cancer cell secretome and biomarker discovery.